Literature DB >> 24518699

Literature review with PGI guidelines for delineation of clinical target volume for intact carcinoma cervix.

Anshuma Bansal, Firuza D Patel1, Bhavana Rai, Abhishek Gulia, Bhaswanth Dhanireddy, S C Sharma.   

Abstract

For definitive treatment of carcinoma cervix with conformal radiation techniques, accurate target delineation is vitally important, yet a consensus definition of clinical target volume (CTV) remains variable within the literature. The aim of the present article is to review the guidelines for CTV delineation published in the literature and to present the guidelines practiced at our institute. For this a literature pub med/medline search was performed from January 2000 to December 2012 and reviewed to identify published articles on guidelines for CTV primary and pelvic lymph node (LN) delineation for carcinoma cervix. Taking into consideration the traditional bony landmark based fields for treating cancer cervix, the knowledge of the patterns of disease spread and recurrence and the findings from imaging studies identifying typical anatomic distributions of areas at risk of harbouring subclinical disease, the differences in various guidelines have been analyzed and discussed. The CTV in cervical cancer consists of the CTV nodal and CTV primary. In all the published guidelines, CTV nodal consists of common iliac, external iliac, internal iliac, pre-sacral and obturator group of lymph nodes, and CTV primary consists of the gross tumor volume, uterine cervix, uterine corpus, parametrium, upper third of vagina and uterosacral ligaments. The various guidelines differ however, in the definition for these individual component structures. This is the first report to provide the complete set of guidelines for delineating both the CTV primary and CTV nodal in combination.

Entities:  

Mesh:

Year:  2013        PMID: 24518699     DOI: 10.4103/0973-1482.126450

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  5 in total

1.  Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.

Authors:  Jen-Yu Cheng; Eng-Yen Huang; Shun-Neng Hsu; Chong-Jong Wang
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

2.  A prospective comparative dosimetric study between diffusion weighted MRI (DWI) & T2-weighted MRI (T2W) for target delineation and planning in cervical cancer brachytherapy.

Authors:  Rishabh Kumar; Geeta S Narayanan; Bhaskar Vishwanthan; Sowmya Narayanan; Sanjeet Mandal
Journal:  Rep Pract Oncol Radiother       Date:  2020-10-28

3.  Obesity in patients with carcinoma cervix increases the risk of adverse events.

Authors:  Ramaiah Vinay Kumar; Suman Bhasker
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-26

4.  Prospective observational study evaluating acute and delayed treatment related toxicities of prophylactic extended field volumetric modulated arc therapy with concurrent cisplatin in cervical cancer patients with pelvic lymph node metastasis.

Authors:  N Ballari; B Rai; A Bahl; B R Mittal; S Ghoshal
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2021-03-09

5.  Comparison of dosimetric data of bone marrow between standard IMRT and bone marrow sparing IMRT in carcinoma cervix.

Authors:  Lucy Pattanayak; Samir Mohanta; Sasmita Panda; Manoranjan Mohapatra
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.